Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
Michelle R. WISE, Charlotte Farrant, Catherine Coop
Abstract
Michelle R. WISE, Charlotte Farrant, Catherine Coop
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of the levonorgestrel intrauterine system (LNG‐IUS) for treatment of endometrial hyperplasia (EH) with or without atypia.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of the levonorgestrel intrauterine system (LNG‐IUS) for treatment of endometrial hyperplasia (EH) with or without atypia.
Key concepts: Levonorgestrel, Endometrial hyperplasia, Atypia, Medicine, Gynecology, Intrauterine device, Obstetrics, Hyperplasia